Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AVANTBISE
- Development stage
- Unknown
- Lead developer
- Wakamoto
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
- Administration
- Buccal, Oral, Topical
01
Overview
AVANTBISE is a brand of oral care products developed by Wakamoto Pharmaceutical, which includes medicated toothpastes and oral tablets. The product line is designed to prevent bad breath, sensitive teeth, periodontitis, gingivitis, and dental caries. The AVANTBISE medicated toothpaste is formulated with live lactic acid bacteria WB2000 (Enterococcus faecium WB2000) as a cleaning agent, alongside zeolite, beta-glycyrrhetinic acid, pyridoxine hydrochloride, and aluminum lactate (for sensitive teeth). The AVANTBISE Oral Tablets are formulated with Lactobacillus salivarius WB21 and green tea catechin (epigallocatechin gallate, EGCg) to restore the balance of oral flora and neutralize bad breath-causing gases. These products are marketed in Japan as quasi-drugs and dietary supplements.
- Brand names
- AVANTBISEAVANTBISE Oral TabletsAvanBeads
- Other names
- アバンビーズ
Beyond the preview
Go deeper on AVANTBISE.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AVANTBISE.